相关实验视频
Updated: Jul 22, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
基因网络分析预测了NSCLC患者免疫治疗的临床反应
Federico Cucchiara1, Stefania Crucitta1, Iacopo Petrini2
1Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Lung cancer (Amsterdam, Netherlands)
|July 20, 2023
概括
染色体重塑和细胞-细胞信号基因网络的突变预测了非小细胞肺癌中对免疫检查点抑制剂的反应. 这些基因特征改善了晚期肺癌患者的治疗个性化.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 在非小细胞肺癌 (NSCLC) 中,免疫检查点抑制剂 (ICI) 的预测生物标志物产生了有争议的结果.
- 基因网络分析为了解瘤生物学和预测治疗反应提供了一种新的方法.
研究的目的:
- 为了识别基因网络的签名,预测ICI响应在先进的NSCLC.
- 评估这些特征在治疗个性化中的临床实用性.
主要方法:
- 利用了来自cBioPortal和TCGA的临床数据和遗传资料,用于644种高级NSCLC.
- 在243个ICI治疗的NSCLC中使用突变基因网络分析和K-means集群识别了免疫疗法响应特征.
- 在242个病例的外部数据集中验证了签名预测值,并与159名用化疗治疗的NSCLC进行了比较.
主要成果:
- 染色体重塑通路基因 (A签名) 和/或细胞对细胞信号通路基因 (B签名) 的至少两种突变预测了ICI治疗高级NSCLC的积极反应.
- 综合签名显示了第一线免疫疗法和ICI组合治疗的最佳性能.
- 与标准化疗相比,签名显示了预测价值.
结论:
- 染色体重塑和细胞对细胞信号基因的变化有助于免疫逃避,并预测免疫疗法易感性.
- 突变基因网络分析对于识别关键的生物相互作用和个性化NSCLC治疗是有价值的.
- 这些发现支持使用基因网络分析来优化NSCLC的免疫疗法选择.
相关概念视频
02:26Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
01:27Cytotoxic T Cells-mediated Immune Response
977
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
977
01:27Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560